ImmunoPrecise has outperformed the broader market in a spectacular fashion. As of now, IPA’s YTD performance stands at +81.64%, a staggering increase compared to the S&P 500’s YTD performance of just ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Inflammation serves as a biological response to harmful stimuli, playing a crucial role in bodily defense but also leading to various chronic conditions ...

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with an alcohol) to be locked treasure chests of possibilities. Ubiquitous as ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Announcing a new publication for Acta Materia Medica journal. Cardiovascular diseases (CVDs) pose a significant threat to human health due to the high mortality and morbidity rates. Traditional drugs ...

The governor also acknowledged the unique challenges posed by the current wave of synthetic drugs, describing them as more life-threatening than traditional drugs. He pointed out that this has become ...

The field of drug discovery faces many time-honored challenges. These include high costs, long development times and high rates of failure. The rise of artificial intelligence (AI) technology has been ...